Home > News > Congestive Heart Failure (CHF) Management in Dogs
Jun.2025 09

Congestive Heart Failure (CHF) Management in Dogs

Introduction
For cases due to Myxomatous Mitral Valve Disease (MMVD) or Dilated Cardiomyopathy (DCM)
Details


1. Medical Management

Drug

Purpose

Notes

Furosemide (or Torsemide)

Diuretic – reduces fluid accumulation (lungs, abdomen)

Monitor kidney function and electrolytes

Pimobendan

Positive inotrope and vasodilator – improves contractility and reduces workload

Strong evidence for MMVD and DCM

ACE Inhibitors (Enalapril, Benazepril)

Reduce afterload and RAAS activation

Monitor kidney values and BP

Spironolactone

Aldosterone antagonist – supports diuretic therapy

May slow disease progression

Antiarrhythmics (Sotalol, Mexiletine)

Control ventricular arrhythmias

Commonly needed in DCM

🔶 Note: Pimobendan is a cornerstone therapy for both MMVD and DCM. It significantly improves quality of life and survival time in dogs with heart failure. Its dual action—supporting heart muscle contraction and dilating blood vessels—makes it a must-have in canine CHF treatment plans.

2. Dietary and Lifestyle Recommendations

 

- Low sodium diet to reduce fluid retention (use therapeutic cardiac diets).

- Ensure adequate calorie intake to prevent muscle wasting (cachexia).

- Supplement with omega-3 fatty acids for inflammation and appetite support.

- Avoid overexertion. Allow only controlled, light activity.

- Maintain hydration but follow veterinary advice on fluid restriction.

 

3. Monitoring and Follow-Up

Parameter

Frequency

Notes

Thoracic radiographs

Every 3–6 months or with clinical signs

Assess pulmonary edema and heart size

Echocardiography

Every 6–12 months

Evaluate heart function and disease progression

Blood tests

Every 1–3 months

Monitor renal values, electrolytes (especially with furosemide, ACEi)

Respiratory rate at rest

Daily at home

>30 bpm at rest may indicate fluid buildup

Blood pressure

Regularly

Especially if on ACE inhibitors or with arrhythmias

4. Signs of CHF Decompensation

 

Seek veterinary help if you notice:

- Increased respiratory rate or effort

- Coughing or wheezing

- Lethargy, weakness, collapse

- Loss of appetite or weight

- Abdominal distension (ascites)

 

5. Prognosis and Optional Advanced Testing

 

- MMVD: With proper treatment, dogs can live for months to years after CHF onset.

- DCM: Prognosis is typically poorer, especially with advanced systolic dysfunction or arrhythmias.

 

Optional tests:

- NT-proBNP or Cardiac Troponin I for cardiac stress or damage

- 24-hour Holter monitoring for arrhythmia detection in DCM breeds